Remplir will get to market, the product has standout benefits, it is only a matter of time.
Striate is also an amazing product that has also shown the company has the ability to commercialise products with world leading distributors. The take up of Striate in the marketplace has already surpassed company expectations in this very early stage of commercialisation.
The future is very bright, I expect $5 plus is not unrealistic upon Remplir achieving US approval.
Media thread, page-307
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.5¢ | $49.66K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20305 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 77938 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |